Showing results (711-720 of 834) with videos related to

Sort By:
Pageof 84
Cancer Research|October 30, 2003
Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypesSophie Godard, Gad Getz, Mauro Delorenzi, et al.
Brain : a Journal of Neurology|April 15, 2021
De novo purine biosynthesis is a major driver of chemoresistance in glioblastomaJack M Shireman, Fatemeh Atashi, Gina Lee, et al.
Neuro-Oncology Advances|February 29, 2024
A multi-institutional phase I study of acetazolamide with temozolomide in adults with newly diagnosed <i>MGMT</i>-methylated malignant gliomaRiley K Driscoll, Sean B Lyne, David J Voce, et al.
Journal of the American Chemical Society|April 25, 2017
Crystal-Phase Transitions and Photocatalysis in Supramolecular ScaffoldsRoman V Kazantsev, Adam J Dannenhoffer, Adam S Weingarten, et al.
Blood|February 21, 2004
Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 scheduleMichele Ghielmini, Shu-Fang Hsu Schmitz, Sergio B Cogliatti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiformeM J van den Bent, W Grisold, D Frappaz, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2018
Diagnostic value of <sup>18</sup>F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary siteFabian Wolpert, Michael Weller, Anna Sophie Berghoff, et al.
Nature Communications|February 23, 2024
Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trialAlexandre Carpentier, Roger Stupp, Adam M Sonabend, et al.
The New England Journal of Medicine|March 11, 2005
MGMT gene silencing and benefit from temozolomide in glioblastomaMonika E Hegi, Annie-Claire Diserens, Thierry Gorlia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2011
Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor GroupR Stupp, A Tosoni, J E C Bromberg, et al.
Pageof 84